Article info
Extended report
Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis
- John C Davis, Jr, Associate Professor of Medicine, University of California, San Francisco, 533 Parnassus Avenue, Box 0633, Room U 386, San Francisco, CA 94143-0633 USA; jdavis{at}medicine.ucsf.edu
Citation
Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis
Publication history
- Accepted October 2, 2007
- First published October 29, 2007.
Online issue publication
February 21, 2008
Article Versions
- Previous version (29 October 2007).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2008 BMJ Publishing Group and European League Against Rheumatism